Physician profile
Jonathan David Brouse
NPI 1568960664
$1,220.23
in general payments reported to CMS, 2019-2025
20 companies · $458 in 2025
The $458 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $273 · 2023: $191 · 2024: $299 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $836 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $835.53 |
| Education | $111.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $225.19 | 2023-2025 | |
| Glaxosmithkline, LLC. | $196.23 | 2021-2025 | Nucala |
| Optinose US, INC. | $113.19 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $111.94 | 2024-2025 | |
| Aerin Medical INC. | $96.93 | 2025 | |
| Abbvie INC. | $86.50 | 2021-2023 | |
| Inspire Medical Systems, INC. | $57.73 | 2024-2025 | Inspire |
| Pfizer INC. | $45.62 | 2021 | |
| Kaleo, INC. | $41.26 | 2023 | Auvi-Q |
| Biohaven Pharmaceuticals, INC. | $35.32 | 2021 | |
| Medtronic, INC. | $33.67 | 2023 | Propel |
| Lilly USA, LLC | $33.66 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $24.57 | 2025 | |
| Integra Lifesciences Corporation | $23.31 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Hologic Sales and Service, LLC | $18.96 | 2023 | Coolseal Generator |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $16.34 | 2021 | |
| Lundbeck LLC | $16.30 | 2021 | |
| Sunovion Pharmaceuticals INC. | $15.65 | 2021 | |
| Eisai INC. | $15.17 | 2021 | |
| Clarus Therapeutics INC. | $12.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Brouse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.